Optical coherence tomography of the macula in congenital achromatopsia

Investigative Ophthalmology and Visual Science

Volumn 48, Issue 5, 2007, Pages 2249-2253

  Varsányi, Balázs ^a   Somfai, Gábor Márk ^a   Lesch, Balázs ^a   Vámos, Rita ^a   Farkas, Ágnes ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ANATOMICAL VARIATION; ARTICLE; CLINICAL ARTICLE; COLOR BLINDNESS; CONTROLLED STUDY; HUMAN; MEASUREMENT; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; RETINA; RETINA MACULA LUTEA; STATISTICAL SIGNIFICANCE; ADULT; AGED; CHILD; COLOR VISION DEFECT; FEMALE; MALE; METHODOLOGY; PATHOLOGY; PRESCHOOL CHILD; VISUAL SYSTEM EXAMINATION;

ADULT; AGED; CHILD; CHILD, PRESCHOOL; COLOR VISION DEFECTS; DIAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL; FEMALE; HUMANS; MACULA LUTEA; MALE; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 34250201456     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.06-1173     Document Type: Article

References (24)

1. Francois J. Heredity in Ophthalmology. St. Louis: CV Mosby; 1961.
2. Sharpe LT, Nordby K. Total Colour Blindness: an Introduction. Cambridge, UK: Cambridge University Press; 2006.
3. Rüther K, Sharpe LT, Zrenner E. Dual rod pathways in complete achromatopsia. Ger J Ophthalmol. 1994;3:433-436.
4. Harrison H, Hoefnagel D, Haynward JN. Congenital total color-blindness, a clinico-pathological report. Arch Ophthalmol. 1960;64:685-692.
5. Falls HF, Wolter JR, Alpern M. Typical total monochromacy. Arch Ophthalmol. 1965;74:610-616.
6. Biel M, Seeliger M, Pfeifer A. Selective loss of function in mice lacking the cyclic nucleotide-gated channel CNG3. Proc Natl Acad Sci USA. 1999;96:7553-7557.
7. Puliafito CA, Hee MR, Lin CP, et al. Imaging of macular diseases with optical coherence tomography. Ophthalmology. 1995;102:217-229.
8. Huang D, Swanson EA, Lin CP, et al. Optical coherence tomography. Science. 1991;254:1178-1181.
9. Barthelmes D, Sutter FK, Kurz-Levin MM, et al. Quantitative analysis of OCT characteristics in patients with achromatopsia and blue-cone monochromatism. Invest Ophthalmol Vis Sci. 2006;47:1161-1166.
10. Marmor MF, Holder GE, Seeliger M. ISCEV Standard for Clinical Electroretinography. Berlin: Springer-Verlag; 2006.
11. Varsanyi B, Wissinger B, Kohl S, Koeppen K, Farkas A. Clinical and genetic features of Hungarian achromatopsia patients. Mol Vis. 2005;11:996-1001.
12. Early Treatment Diabetic Retinopathy Study Research Group. Classification of diabetic retinopathy from fluorescein angiograms. ETDRS Report Number II. Ophthalmology. 1991;98:807-822.
13. Fujimoto JG, Brezinski ME, Tearney GJ, et al. Optical biopsy and imaging using optical coherence tomography. Nat Med. 1995;1:970-972.
14. Drexler W, Sattmann H, Hermann B, et al. Enhanced visualization of macular pathology with the use of ultrahigh-resolution optical coherence tomography. Arch Ophthalmol. 2003;121:695-706.
15. Costa RA, Calucci D, Skaf M, et al. Optical coherence tomography 3: Automatic delineation of the outer neural retinal boundary and its influence on retinal thickness measurements. Invest Ophthalmol Vis Sci. 2004;45:2399-2406.
16. Hee MR, Puliafito CA, Duker JS, et al. Topography of diabetic macular edema with optical coherence tomography. Ophthalmology. 2006;1998:360-370.
17. Werner JS, Bieber ML, Schefrin BE. Senescence of foveal and parafoveal cone sensitivities and their relations to macular pigment density. J Opt Soc Am. 2000;17:1918-1932.
18. Eisner AE, Burns SA, Beausencourt E, Weiter JJ. Foveal cone photopigment distribution: small alterations associated with macular pigment distribution. Invest Ophthalmol Vis Sci. 1998;39:2394-2404.
19. Delori FC, Goger DG, Hammond BR, Snodderly DM, Burns SA. Macular pigment density measured by autofluorescence spectrometry: comparison with reflectometry and heterochromatic flicker photometry. J Opt Soc Am A Opt Image Sci Vis. 2001;18:1212-1230.
20. Bernstein PS, Zhao DY, Wintch SW, et al. Resonance Raman measurement of macular carotinoids in normal subjects and in age-related macular degeneration patients. Ophthalmology. 2002;109:1780-1787.
21. Johnson S, Michaelides M, Aligianis IA. Achromatopsia caused by novel mutation in both CNGA3 and CNGB3. J Med Genet. 2004;41:e20.
22. Kohl S, Varsányi B, Antunes GA, et al. CNGB3 mutations account for 50% of all cases with autosomal recessive achromatopsia. Eur J Hum Genet. 2005;13:302-308.
23. Wissinger B, Gamer D, Jägle H, et al. CNGA3 mutations in hereditary cone photoreceptor disorders. Am J Hum Genet. 2001;69:722-737.
24. Hauswirth WW, Beaufrere L. Ocular gene therapy: Quo vadis? Invest Ophthalmol Vis Sci. 2000;41:2821-2826.